cancer clinical trials in boston, MA
|
Beth Israel Deaconess Medical Center Dept.ofBethIsraelDeaconess(3)
Boston, Massachusetts 02215 Metastatic Melanoma
|
|
Massachusetts General Hospital Cancer Center
Boston, Massachusetts 02114 Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
|
|
Beth Israel Deaconness Medical Center
Boston, Massachusetts 02215 Helicobacter Pylori
|
|
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
Trial Locations Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute Boston University Cancer Research Center Prostate Cancer
|
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Boston Medical Center Brigham and Women's Hospital Tufts Medical Center Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
|
|
Tufts-NEMC Cancer Center
Trial Locations Tufts-NEMC Cancer Center Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Massachusetts General Hospital Breast Cancer
|
|
Dana Farber Cancer Institute
Boston, Massachusetts 02115 Melanoma
|
|
Beth Israel Deaconess Medical Center
Boston, Massachusetts 02215 Anal Cancer
|
|
Beth Israel Deaconess Medical Center
Boston, Massachusetts 02215 Pain, Visceral Pain, Pancreatic Cancer
|
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Massachusetts General Hospital Cancer Center Dana-Farber Cancer Institute Boston Medical Center Brigham and Women's Hospital Tufts Medical Center Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
|
|
DFCI/Children's Hospital of Boston
Boston, Massachusetts 02114 Anemia, Aplastic
|
|
Massachusetts General Hospital Cancer Center
Trial Locations Massachusetts General Hospital Cancer Center Dana-Farber Cancer Institute Neurofibromatosis Type 1, Plexiform Neurofibroma, Spinal Cord Neurofibroma
|
|
Dana-Farber Cancer Institute
Trial Locations Dana-Farber Cancer Institute Boston Medical Center Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
|
|
Dana-Farber Cancer Institute
Boston, Massachusetts 02115 Chronic Lymphocytic Leukemia
|
|
Dana-Farber/Brigham and Women's Cancer Center
Boston, Massachusetts 02115 Cervical Cancer, Endometrial Cancer
|
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Massachusetts General Hospital Dana-Farber/Brigham and Women's Cancer Center Boston University Cancer Research Center Prostate Cancer
|
|
Massachusetts General Hospital
Boston, Massachusetts 02114-2617 Kidney Cancer
|
|
Dana-Farber Cancer Institute
Trial Locations Dana-Farber Cancer Institute Floating Hospital for Children at Tufts Medical Center Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
|
|
New England Medical Center
Trial Locations New England Medical Center Boston University School of Public Health Diethylstilbestrol (DES) Exposure
|
|
Dana-Farber Cancer Institute
Boston, Massachusetts 02115 Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
|
|
Reproductive Endocrine Unit, Massachusetts General Hospital
Boston, Massachusetts 02114 Kallmann's Syndrome, Hypogonadotropic Hypogonadism, Healthy Volunteers
|
|
Dana-Farber Cancer Institute
Trial Locations Dana-Farber Cancer Institute Massachusetts General Hospital Hodgkin's Lymphoma
|
|
Floating Hospital for Children at Tufts Medical Center
Boston, Massachusetts 02111 Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor
|
|
Massachusetts General Hospital Cancer Center
Trial Locations Massachusetts General Hospital Cancer Center Dana-Farber Cancer Institute Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
|
|
Harvard Medical School
Boston, Massachusetts 02115 Colorectal Cancer
|
|
Massachusetts General Hospital
Boston, Massachusetts 02114-2617 Soft Tissue Sarcoma, Fibrous Histiocytoma, Liposarcoma, Leiomyosarcoma, Fibrosarcoma, Synovial Sarcoma
|
|
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts 02115 Brain and Central Nervous System Tumors, Leukemia, Lymphoma, Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
|
|
Brigham and Women´s Hospital
Boston, Massachusetts 02115 Hemophilia A
|
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Massachusetts General Hospital Metastatic Non-hematologic Malignancies
|
